Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

NETWORK × Saline Solution × Head & Neck × Clear all

Phase

Status

Sponsor Class

OTHER 10 NETWORK 1 INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1 Myeloid 1 Lymphoid 1 Head & Neck 1 Gastrointestinal 1

Conditions

Squamous Cell Carcinoma of Head and Neck 1

Interventions

Cisplatin 50 Radiotherapy 31 Fluorouracil 15 Paclitaxel 14 Radiotherapy, Intensity-Modulated 12 Carboplatin 12 Docetaxel 11 Cetuximab 11 Platinum 6 Immunohistochemistry 6 Radiotherapy, Conformal 5 Gene Expression Profiling 5 Radiation 4 Polymerase Chain Reaction 4 Nimorazole 4 Drug Therapy 4 Chemotherapy, Adjuvant 4 1,2-diaminocyclohexaneplatinum II citrate 4 durvalumab 3 Taxes 3 Magnetic Resonance Spectroscopy 3 In Situ Hybridization, Fluorescence 3 Gemcitabine 3 Afatinib 3 vandetanib 2 pembrolizumab 2 dehydroftorafur 2 Surgical Procedures, Operative 2 Specimen Handling 2 Reverse Transcriptase Polymerase Chain Reaction 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03673735 2021-05-10

ADHERE

European Organisation for Research and Treatment of Cancer - EORTC

Phase 3 Withdrawn

Squamous Cell Carcinoma of Head and Neck

Data powered by HemOnc (CC BY 4.0) Colophon ⚡